4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
3D Medicines Inc. (1244) operates in the Biotechnology industry and is headquartered in Qingdao, China with about 162 employees. Its market capitalization is roughly CNY 514 million. In the fiscal year ended 2025-12-31, 1244 reported CNY 356M in revenue and (CNY 178M) in net income.
3D Medicines Inc., a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products in the People's Republic of China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 356M | CNY 446M | CNY 635M | CNY 567M | — |
| Gross Profit | CNY 328M | CNY 409M | CNY 586M | CNY 525M | — |
| Operating Income (EBIT) | (CNY 74M) | (CNY 79M) | (CNY 421M) | (CNY 321M) | — |
| Net Income | (CNY 178M) | (CNY 183M) | (CNY 525M) | (CNY 1.0B) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 936M | CNY 1.2B | CNY 1.4B | CNY 1.3B | — |
| Total Liabilities | CNY 391M | CNY 512M | CNY 558M | CNY 437M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1244 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms